|
Maternal-child health has many medical challenges, such as pre-term birth, that are neither clearly understood nor amenable to straightforward diagnosis with conventional methods. ProteoGenix has applied innovative clinical genomic and proteomic technologies to the focused mission of developing and marketing diagnostic tests during a woman’s pregnancy. No other enterprises have brought these powerful molecular tools to this market sector.
|